A trial for a new itchy skin medicine for people on peritoneal dialysis
Part of Kidney & urinary, Skin clinical trials.
This trial tests if a medication called nalfurafine hydrochloride (taken as a tablet that melts in your mouth) can help reduce moderate to severe itching in people receiving peritoneal dialysis for chronic kidney disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You have chronic kidney failure and have been on peritoneal dialysis for at least 3 months.
- Your itching is not caused by other conditions like allergies, skin infections, or liver disease.
- You have not used certain medications for itching (like antihistamines, steroids, or gabapentin) recently or plan to change them during the trial.
- You do not have serious heart problems, active infections, or cancer that required treatment in the last year.
- You can understand and follow the study procedures and give written consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if anrikefon or nalfurafine improves sleep quality in people on hemodialysis who have chronic kidney disease-related itching. It aims to find a better treatment for both itch and sleep problems.
This study tests a new oral medication, nalfurafine hydrochloride, to see if it helps reduce itching in people on dialysis. It might offer a new option for those whose current itch treatments haven't been effective.
This study tests a medication called nalfurafine to see if it can reduce severe itching (pruritus) that often comes with advanced kidney disease in people on dialysis. If you have moderate to severe itching and have been on dialysis twice a week for more than 6 months, this trial may offer a potential new treatment option.
This trial tests a drug called difelikefalin to see if it safely reduces moderate-to-severe itching in teenagers who are on hemodialysis. Itching is common in kidney disease, and this study aims to find a new treatment option.
This trial tests a drug called difelikefalin to see if it can reduce severe itching in people on hemodialysis for chronic kidney disease. If you have troublesome itching despite dialysis, this treatment might help relieve it.
This study tests a special type of dialysis filter (made of PMMA) to see if it can reduce severe itching and improve quality of life for people on long-term dialysis. If you have bothersome itching that standard treatment hasn't helped, this trial might be an option for you.
Hear when a new Adverse Event trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.